Although neuroendocrine tumors (including neuroendocrine carcinoma, pancreatic endocrine tumor, carcinoid tumour) have historically been considered rare, the diagnosed incidence of neuroendocrine tumors has been increasing in the past decades. Recent statistics suggest that the current number of people with neuroendocrine tumors exceeds 100,000 people in the United States—more than the number of people with other, better known cancers like pancreatic or stomach cancer. The increase in diagnoses parallels increased awareness and knowledge about not only how to diagnose neuroendocrine tumors but also how to effectively treat them.
Shuji Ogino
